A Study to Explore Clinicians’ Point-Of-Care Decision-Making Process and Behavior following a Pharmacogenomics Alert
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 17-007078
Sponsor Protocol Number: 17-007078
About this study
The purpose of this study is to develop a deeper understanding of a clinician’s point-of-care decision making processes following their interaction with a pharmacogenomics CDS alert.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Practicing clinician prescribers (Mayo Clinic, Rochester, MN) who receive a pharmacogenomics alert upon ordering a medication with an established clinical decision support rule in the EHR.
- Practicing clinicians who do not experience a pharmacogenomics alert invoked by clinical decision support when prescribing medications or who do not practice at Mayo Clinic in Rochester, MN.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Carolyn Vitek, Ed.D., M.S.
Closed for enrollment
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available